Abstract
Within the urinary tract, β-adrenergic receptors (AR) are found largely on smooth muscle cells but are also present, at least in the bladder, in the urothelium and on afferent nerves. Our understanding of β-AR subtype expression and function is hampered by a lack of well-validated tools, particularly with regard to β3-AR. Moreover, the β-AR subtypes involved in a specific function may differ between species. In the ureter, β-AR can modulate pacemaker activity and smooth muscle tone involving multiple subtypes. In the human bladder, β-AR promote urine storage. Bladder smooth muscle relaxation primarily involves β3-AR, and the agonists selective for this subtype are in clinical development to treat bladder dysfunction. While prostate and urethra also express β-AR, the overall physiological role in these tissues remains unclear.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aizawa N, Igawa Y, Nishizawa O et al (2010) Effects of CL316, 243, a beta3-adrenoceptor agonist, and intravesical prostaglandin E2 on the primary bladder afferent activity of the rat. Neurourol Urodyn 29(5):771–776
Badawi JK, Seja T, Uecelehan H et al (2007) Relaxation of human detrusor muscle by selective beta-2 and beta-3 agonists and endogenous catecholamines. Urology 69:785–790
Bajor G (1980) Beta-blocking agent facilitating the spontaneous passage of ureteral stones. Int Urol Nephrol 22:33–36
Barendrecht MM, Frazier EP, Vrydag W et al (2009) The effect of bladder outlet obstruction on α1- and β-adrenoceptor expression and function. Neurourol Urodyn 28:349–355
Biers SM, Reynard JM, Brading AF (2006) The effects of a new selective β3-adrenoceptor agonist (GW427353) on spontaneous activity and detrusor relaxation in human bladder. BJU Int 98:1310–1314
Brown SM, Bentcheva-Petkova LM, Liu L et al (2008) β-Adrenergic relaxation of mouse urinary bladder smooth muscle in the absence of large-conductance Ca2+-activated K+-channel. Am J Physiol 295:F1149–F1157
Canda AE, Turna B, Cinar GM et al (2007) Physiology and pharmacology of the human ureter: basis for current and future treatments. Urol Int 78:289–298
Carmena MJ, Clemente C, Carrero I et al (1997) G-Proteins and β-adrenergic stimulation of adenylate cyclase activity in the diabetic rat prostate. Prostate 33:46–54
Chapple CR, Yamaguchi O, Ridder A et al (2008) Clinical proof of concept study (Blossom) shows novel β3 adrenoceptor agonist YM178 is effective and well tolerated in the treatment of symptoms of overactive bladder. Eur Urol Suppl 7:239–239
Chapple C, Wyndaele J-J, van Kerrebroeck P et al (2010) Dose-ranging study of once-daily mirabegron (YM178), a novel selective β3-adrenoceptor agonist, in patients with overactive bladder (OAB). Eur Urol Suppl 9:249–249
Collins S, Quarmby VE, French FS et al (1988) Regulation of the β2-adrenergic receptor and its mRNA in the rat ventral prostate by testosterone. FEBS Lett 233:173–176
Danuser H, Weiss R, Abel D et al (2001) Systemic and topical drug administration in the pig ureter: effect of phosphodiesterase inhibitors α1, β and β2-adrenergic receptor agonists and antagonists on the frequency and amplitude of ureteral contractions. J Urol 166:714–720
Drescher P, Eckert RE, Madsen PO (1994) Smooth muscle contractility in prostatic hyperplasia: role of cyclic adenosine monophosphate. Prostate 25:76–80
Durant PA, Lucas PC, Yaksh TL (1988) Micturition in the unanaesthetized rat: spinal vs. peripheral pharmacology of the adrenergic system. J Pharmacol Exp Ther 245:426–435
Ehlert FJ, Ahn S, Pak KJ et al (2007) Neuronally release acetylcholine acts on the M2 muscarinic receptor to oppose the relaxant effect of isoproterenol on cholinergic contractions in mouse urinary bladder. J Pharmacol Exp Ther 322:631–637
Frazier EP, Schneider T, Michel MC (2006) Effects of gender, age and hypertension on β-adrenergic receptor function in rat urinary bladder. Naunyn-Schmiedeberg’s Arch Pharmacol 373:300–309
Frazier EP, Peters SLM, Braverman AS et al (2008) Signal transduction underlying control of urinary bladder smooth muscle tone by muscarinic receptors and β-adrenoceptors. Naunyn-Schmiedeberg’s Arch Pharmacol 377:449–462
Fukumoto Y, Yoshida M, Dokita S et al (1993) The reversal effect of insulin on diabetes-induced alterations in beta adrenergic and muscarinic receptors in rat prostate. J Urol 149:1602–1607
Garcia-Sacristan A, Casanueva CR, Castilla C et al (1984) Adrenergic receptors in the urethra and prostate of the horse. Res Vet Sci 36:57–60
Goepel M, Wittmann A, Rübben H et al (1997) Comparison of adrenoceptor subtype expression in porcine and human bladder and prostate. Urol Res 25:199–206
Gousse A, Yoshida M, Weiss RM et al (1991) Beta adrenergic receptor alterations in diabetic rat prostate: effects of insulin and dietary myoinositol. Prostate 19:121–131
Gruneberger A (1984) Treatment of motor urge incontinence with clenbuterol and flavoxate hydrochloride. Br J Obst Gynaecol 91:275–278
Guthrie PD, Freeman MR, Liao ST et al (1990) Regulation of gene expression in rat prostate by androgen and β-adrenergic receptor pathways. Mol Endocrinol 4:1343–1353
Hamdani N, van der Velden J (2009) Lack of specificity of antibodies directed against human beta-adrenergic receptors. Naunyn-Schmiedeberg’s Arch Pharmacol 379:403–407
Haynes JM, Hill SJ (1997) β-Adrenoceptor-mediated inhibition of α1-adrenoceptor-mediated and field stimulation-induced contractile responses in the prostate of the guinea pig. Br J Pharmacol 122:1067–1074
Hernandez M, Prieto D, Simonsen U et al (1992) Noradrenaline modulates smooth muscle activity of the isolated intravesical ureter of the pig through different types of adrenoceptors. Br J Pharmacol 107:931
Hicks A, McCafferty GP, Riedel E et al (2007) GW427353 (solabegron), a novel, selective β3-adrenergic receptor agonist, evokes bladder relaxation and increases micturition reflex threshold in the dog. J Pharmacol Exp Ther 323:202–209
Hristov KL, Cui X, Brown SM et al (2008) Stimulation of β3-adrenoceptor relaxes rat urinary bladder smooth muscle via activation of the large-conductance Ca2+-activated K+ channels. Am J Physiol 295:C1344–C1353
Hudman D, Elliott RA, Whitakker P et al (2001) Inhibition of the contractile responses of isolated human and rat bladders by clenbuterol. J Urol 166:1969–1973
Igawa Y, Yamazaki Y, Takeda H et al (1998) Possible β3-adrenoceptor-mediated relaxation of the human detrusor. Acta Physiol Scand 164:117–118
Igawa Y, Yamazaki Y, Takeda H et al (2001) Relaxant effects of isoproterenol and selective β3-adrenoceptor agonists on normal, low compliant and hyperreflexic human bladders. J Urol 165:240–244
Imanishi M, Tomishima Y, Itou S et al (2008) Discovery of a novel series of biphenyl benzoic acid derivatives as potent and selective human β3-adrenergic receptor agonists with good oral bioavailability. Part I. J Med Chem 51:1925–1944
Jung H, Norby B, Frimodt-Moller PC et al (2008) Endoluminal isoproterenol irrigation decreases renal pelvic pressure during flexible ureteroscopy: a clinical, randomized, controlled study. Eur Urol 54:1404–1413
Kaidoh K, Igawa Y, Takeda H et al (2002) Effects of selective β2 and β3-adrenoceptor agonists in detrusor hyperreflexia in conscious cerebral infarcted rats. J Urol 168:1247–1252
Kalodimos PJ, Ventura S (2001) β2-Adrenoceptor-mediated inhibition of field stimulation induced contractile responses of the smooth muscle of the rat prostate gland. Eur J Pharmacol 431:81–89
Klausner AP, Rourke KF, Miner AS et al (2009) Potentiation of carbachol-induced detrusor smooth muscle contractions by β-adrenoceptor activation. Eur J Pharmacol 606:191–198
Labadia A, Rivera L, Costa G et al (1987) Alpha- and beta-adrenergic receptors in the horse ureter. Rev Esp Fisiol 43:421–425
Leon LA, Hoffman BE, Gardner SD et al (2008) Effects of the β3-adrenergic receptor agonist disodium 5[(2R)-2-[[(2R)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]propyl]-1, 3-benzodioxole-2, 2, dicarboxylate (L-316243) on bladder micturition reflex in spontaneously hypertensive rats. J Pharmacol Exp Ther 326:178–185
Levin RM, Wein AJ (1979) Quantitative analysis of alpha and beta adrenergic receptor densities in the lower urinary tract of the dog and the rabbit. Invest Urol 17:75–77
Lindholm P, Lose G (1986) Terbutaline (Bricanyl) in the treatment of female urge incontinence. Urol Int 41:158–160
Mayo ME, Halbert SA (1981) The effect of autonomic drugs on ureteric peristalsis: a canine in vivo study. Urol Res 9:209–216
McLeod DG, Reynolds DG, Swan KG (1973) Adrenergic mechanisms in the canine ureter. Am J Physiol 224:1054–1058
Meister B, Dagerlind A, Nicholas AP et al (1994) Patterns of messenger RNA expression for adrenergic receptor subtypes in rat kidney. J Pharmacol Exp Ther 268:1605–1611
Michel MC, Barendrecht MM (2008) Physiological and pathological regulation of the autonomic control of urinary bladder contractility. Pharmacol Ther 117:297–312
Michel MC, Chapple CR (2009) Basic mechanisms of urgency: basic and clinical evidence. Eur Urol 56:298–308
Michel MC, Parra S (2008) Similarities and differences in the autonomic control of airway and urinary bladder smooth muscle. Naunyn-Schmiedeberg’s Arch Pharmacol 378:217–224
Michel MC, Sand C (2009) Effect of pre-contraction on β-adrenoceptor-mediated relaxation of rat urinary bladder. World J Urol 27:711–715
Michel MC, Vrydag W (2006) α1-, α2- and β-adrenoceptors in the urinary bladder, urethra and prostate. Br J Pharmacol 147:S88–S119
Miyatake R, Tomiyama Y, Murakami M et al (2001) Effects of isoproterenol and butylscopolamine on the friction between an artificial stone and the intraureteral wall in anaesthetized rabbits. J Urol 166:1083–1087
Monica FZT, Bricola AAO, Bau FR et al (2008) Long-term nitric oxide deficiency causes muscarinic supersensitivity and reduces β3-adrenoceptor-mediated relaxation, causing rat detrusor overactivity. Br J Pharmacol 153:1659–1668
Mori A, Miwa T, Sakamoto K et al (2010) Pharmacological evidence for the presence of functional β3-adrenoceptors in rat retinal blood vessels. Naunyn-Schmiedeberg’s Arch Pharmacol 382(2):119–126
Morita T, Suzuki T (1984) Effects of beta-adrenergic agents on the pacemaker of ureteral peristalsis. Urol Int 39:154–158
Morita T, Ando M, Kihara K et al (1994) Function and distribution of autonomic receptors in canine ureteral smooth muscle. Neurourol Urodyn 13:315–321
Murakami M, Tomiyama Y, Hayakawa K et al (2000) Effects of β-adrenergic stimulation on acutely obstructed ureter in dogs. J Pharmacol Exp Ther 292:67–75
Murakami S, Chapple CR, Akino H et al (2007) The role of the urothelium in mediating bladder responses to isoprenaline. BJU Int 99:669–673
Nomiya M, Yamaguchi O (2003) A quantitative analysis of mRNA expression of α1 and β-adrenoceptor subtypes and their functional roles in human normal and obstructed bladders. J Urol 170:649–653
Normandin DE, Lodge NJ (1996) Pharmacoalogical characterization of the isolated canine prostate. J Urol 155:1758–1761
Oostendorp J, Preitner F, Moffatt J et al (2000) Contribution of β-adrenoceptor subtypes to relaxation of colon and oesophagus and pacemaker activity of ureter in wild-type and β3-adrenoceptor knockout mice. Br J Pharmacol 130:747–758
Otsuka A, Shinbo H, Hasebe K et al (2008a) Effects of a novel β3-adrenoceptor agonist, AJ-9677, on relaxation of the detrusor muscle: an in vitro study. Int J Urol 15:1072–1076
Otsuka A, Shinbo H, Matsumoto R et al (2008b) Expression and functional role of β-adrenoceptors in the human urinary bladder. Naunyn-Schmiedeberg’s Arch Pharmacol 377:473–481
Palm D, Lang K, Niggemann B et al (2006) The norepinephrine-driven metastasis development of PC-3 human prostate cancer cells in BALB/c nude mice is inhibited by β-blockers. Int J Cancer 118:2744–2749
Park Y-C, Tomiyama Y, Hayakawa K et al (2000) Existence of a β3-adrenoceptor and its functional role in the human ureter. J Urol 164:1364–1370
Peters HJ, Parekh N, Popa G (1979) Effects of adrenergic and cholinergic agents on ureteral functions in dogs. Urol Int 34:137–146
Poyet P, Gagne B, Labrie F (1986) Characteristics of the β-adrenergic stimulation of adenylate cyclase activity in rat ventral prostate and its modulation by androgens. Prostate 9:237–245
Pradidarcheep W, Stallen J, Labruyere WT et al (2009) Lack of specificity of commercially available antisera against muscarinic and adrenergic receptors. Naunyn-Schmiedeberg’s Arch Pharmacol 379:397–402
Purvis K, Rui H, Gordeladze JO et al (1986) Hormonal activation of the adenylyl cyclases of the rat and human prostate gland. Prostate 8:11–24
Springer JP, Kropp BP, Thor KB (1994) Facilitatory and inhibitory effects of selective norepinephrine reuptake inhibitors on hypogastric nerve-evoked urethral contractions in the cat: a prominent role of urethral β-adrenergic receptors. J Urol 152:515–519
Takasu T, Ukai M, Sato S et al (2007) Effect of YM178, a novel selective β3-adrenoceptor agonist, on bladder function. J Pharmacol Exp Ther 321:642–647
Takeda M, Obara K, Mizusawa T et al (1999) Evidence for β3-adrenoceptor subtypes in relaxation of the human urinary bladder detrusor: analysis by molecular biological and pharmacologocial methods. J Pharmacol Exp Ther 288:1367–1373
Takeda H, Yamazaki Y, Igawa Y et al (2002) Effects of β3-adrenoceptor stimulation on prostaglandin E2-induced bladder hyperreactivity and on the cardiovascular system in conscious rats. Neurourol Urodyn 21:558–565
Takeda H, Matsuzawa A, Igawa Y et al (2003) Functional characterization of β-adrenoceptor subtypes in the canine and rat lower urinary tract. J Urol 170:654–658
Takemoto J, Masumiya H, Nunoki K et al (2008) Potentiation of potassium currents by beta-adrenoceptor agonists in human urinary bladder smooth muscle cells: a possible electrical mechanism of relaxation. Pharmacology 81:251–258
Thind P, Lose G, Colstrup H et al (1993a) The effect of pharmacological stimulation and blockade of autonomic receptors on the urethral pressure and power generation during coughing and squeezing of the pelvic floor in healthy females. Scand J Urol Nephrol 27:519–525
Thind P, Lose G, Colstrup H et al (1993b) The influence of β-adrenoceptor and muscarinic receptor agonists and antagonists on the static urethral closure function in healthy females. Scand J Urol Nephrol 27:31–38
Tindall AR (1972) Preliminary observations on the mechanical and electrical activity of the rat ureter. J Physiol (London) 223:633–647
Tomiyama Y, Hayakawa K, Shinagawa K et al (1998) β-Adrenoceptor subtypes in the ureteral smooth muscle of rats, rabbits and dogs. Eur J Pharmacol 352:269–278
Tomiyama Y, Murakami M, Hayakawa K et al (2003a) Pharmacological profile of KUL-7211, a selective β-adrenoceptor agonist, in isolated ureteral smooth muscle. J Pharmacol Sci 92:411–419
Tomiyama Y, Murakami M, Yamazaki Y et al (2003b) Comparison between CL-316243- and CGP-12177A-induced relaxations in isolated canine ureter. Pharmacology 68:140–146
Tsujii T, Azuma H, Yamaguchi T et al (1992) A possible role of decreased relaxation mediated by β-adrenoceptors in bladder outlet obstruction by benign prostatic hypertrophy. Br J Pharmacol 107:803–807
Tyagi P, Thomas CA, Yoshimura N et al (2009) Investigations into the presence of functional β1, β2 and β3-adrenoceptors in urothelium and detrusor of human bladder. Int Braz J Urol 35:76–83
Tzortzis V, Mamoulakis C, Rioja J et al (2009) Medical expulsive therapy for distal ureteral stones. Drugs 69:677–692
Ursino MG, Vasina V, Raschi E et al (2009) The β3-adrenoceptor as a therapeutic target: current perspectives. Pharmacol Res 59:221–234
Vrydag W, Michel MC (2007) Tools to study β3-adrenoceptors. Naunyn-Schmiedeberg’s Arch Pharmacol 374:385–398
Vrydag W, Alewijnse AE, Michel MC (2008) Do gene polymorphisms alone or in combination affect the function of human β3-adrenoceptors? Br J Pharmacol 156:127–134
Wanajo I, Tomiyama Y, Yamazaki Y et al (2004) Pharmacological characterization of β-adrenoceptor subtypes mediating relaxation in porcine isolated utereral smooth muscle. J Urol 172:1155–1159
Wanajo I, Tomiyama T, Tadachi M et al (2005) The potency of KUL-7211, a selective ureteral relaxant, in isolated canine ureter: comparison with various spasmolytics. Urol Res 33:409–414
Weiss RM, Basset AL, Hoffman BF (1978) Adrenergic innervation of the ureter. Invest Urol 16:123–127
Witte LPW, de Haas N, Mammen M et al (2009) Roles of M2 and M3 muscarinic receptors in the modulation of β-adrenoceptor-mediated relaxation of the rat urinary bladder. pA2 online 6:http://www.pA2online.org/abstracts/Vol6Issue4abst053.pdf
Wuest M, Eichhorn B, Grimm MO et al (2009) Catecholamines relax detrusor through β2-adrenoceptors in mouse and β3-adrenoceptors in man. J Pharmacol Exp Ther 328:213–222
Yamamoto Y, Koike K (2000) The effects of β-adrenoceptor agonists on KCl-induced rhythmic contraction in the ureter of guinea pig. J Smooth Muscle Res 36:13–19
Yamanishi T, Yasuda K, Kitahara S et al (2006) Effects of 138-355, a β3-adrenoceptor selective agonist, on relaxation of the human detrusor muscle in vitro. Neurourol Urodyn 25:815–819
Yamazaki Y, Tatemichi S, Maruyama I et al (2002) Characterization of KUC-7483 and its active metabolite, KUC-7322, a selective beta3-adrenoceptor agonist, on bladder function in rats. https://www.icsoffice.org/publications/2002/pdf/095.pdf
Yoshikawa S, Kanie S, Kobayashi R et al (2009) TRK-380, a novel B3-adrenoceptor (AR) agonist, decreases voiding frequency in rats with formalin-induced pollakiuria and suppresses the non-voiding contractions (NVCS) in bladder outlet obstruction (BOO). https://www.icsoffice.org/ASPNET_Membership/Membership/Abstracts/Publish/47/000505.pdf
Yoshikawa S, Morimoto T, Okazaki S et al (2009) TRK-380, a novel B3-adrenoceptor (AR) agonist with potent agonistic activity, functionally relaxes detrusor strips in some species including humans. https://www.icsoffice.org/ASPNET_Membership/Membership/Abstracts/Publish/47/000502.pdf
Acknowledgments
Work in the author’s lab has been supported by grants from the Deutsche Forschungsgemeinschaft, Coordination Theme 1 (Health) of the European Community’s FP7, Grant agreement number HEALTH-F2-2008-223234, Astellas and Boehringer Ingelheim.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Michel, M.C. (2011). β-Adrenergic Receptor Subtypes in the Urinary Tract. In: Andersson, KE., Michel, M. (eds) Urinary Tract. Handbook of Experimental Pharmacology, vol 2011. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-16499-6_15
Download citation
DOI: https://doi.org/10.1007/978-3-642-16499-6_15
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-16498-9
Online ISBN: 978-3-642-16499-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)